ArticleLancet regional health. Americas2024

Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study.

Neil R Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.